| 1 |
Iltar U, Sözel H, Sözel YK, Ataş Ü, Yücel OK, Salim O, Aydin F, Undar L. Prognostic impact of the psoas muscle index, a parameter of sarcopenia, in patients with diffuse large B-cell lymphoma treated with rituximab-based chemoimmunotherapy. Leukemia & Lymphoma 2021;62:1098-106. [DOI: 10.1080/10428194.2020.1856833] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 2 |
Lucijanic M, Huzjan Korunic R, Sedinic M, Kovacevic S, Atic A, Pejsa V, Kusec R. Baseline and progressive adipopenia in newly diagnosed patients with diffuse large B-cell lymphoma with unfavorable features are associated with worse clinical outcomes. Leuk Lymphoma 2022;:1-10. [PMID: 35105266 DOI: 10.1080/10428194.2022.2034160] [Reference Citation Analysis]
|
| 3 |
Huang LW, Sun D, Link TM, Lang T, Ai W, Kaplan LD, Steinman MA, Andreadis C. High incidence of fractures after R-CHOP-like chemotherapy for aggressive B-cell non-Hodgkin lymphomas. Support Care Cancer 2021;29:5399-408. [PMID: 33694088 DOI: 10.1007/s00520-021-06120-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 4 |
Yoshida S, Sakurai G, Yahata T. Prevalence of low skeletal muscle quantity and quality and their associated factors in patients before allogeneic hematopoietic stem cell transplantation. Intern Emerg Med 2021. [PMID: 34387840 DOI: 10.1007/s11739-021-02828-3] [Reference Citation Analysis]
|
| 5 |
Albano D, Dondi F, Ravanelli M, Tucci A, Farina D, Giubbini R, Treglia G, Bertagna F. Prognostic Role of "Radiological" Sarcopenia in Lymphoma: A Systematic Review. Clin Lymphoma Myeloma Leuk 2022;22:e340-9. [PMID: 34893457 DOI: 10.1016/j.clml.2021.11.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Lucijanic M, Huzjan Korunic R, Sedinic M, Kusec R, Pejsa V. More Pronounced Muscle Loss During Immunochemotherapy is Associated with Worse Clinical Outcomes in Newly Diagnosed Patients with Diffuse Large B-Cell Lymphoma with Unfavorable Features. Ther Clin Risk Manag 2021;17:1037-44. [PMID: 34594106 DOI: 10.2147/TCRM.S323749] [Reference Citation Analysis]
|
| 7 |
Lucijanić M, Korunić RH, Sedinić M, Kušec R, Pejša V. Prognostic impact of psoas muscle index in patients with diffuse large B-cell lymphoma might be dependent on the immunochemotherapy type. Leuk Lymphoma 2021;:1-4. [PMID: 33908324 DOI: 10.1080/10428194.2021.1919667] [Reference Citation Analysis]
|
| 8 |
Xu X, He D, Tian M, Wu H, Jin X. Prognostic Value of Sarcopenia in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP: A Systematic Review and Meta-Analysis. Front Nutr 2022;9:816883. [DOI: 10.3389/fnut.2022.816883] [Reference Citation Analysis]
|
